Vanda Pharmaceuticals Announces that U S Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of.
Wish List 2023: Local nonprofits tell us what they need — and how you can help pennlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pennlive.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced results from its Phase III clinical study, VP-VLY-686-3303, evaluating the.